What is Biosero?
Biosero operates at the intersection of high-throughput robotics and digital workflow management. The company is best known for its Green Button Go platform, which serves as a vendor-agnostic orchestration layer for laboratory instrumentation. By enabling seamless communication between disparate hardware systems, Biosero allows researchers to automate intricate protocols in genomics, drug discovery, and clinical diagnostics. Their market position is reinforced by a footprint that spans over 1,000 laboratories, including partnerships with the world's leading pharmaceutical enterprises, effectively positioning them as the connective tissue of modern scientific research environments.
How much funding has Biosero raised?
Biosero has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Biosero
PPP
Public-Private Partnership
What's next for Biosero?
With the support of this late-stage financing, Biosero is poised to accelerate its product roadmap and expand its global service capabilities. The strategic focus will likely shift toward deepening the integration of artificial intelligence within their orchestration software to further optimize experimental throughput and data integrity. As the life sciences industry continues to prioritize speed-to-market and operational efficiency, Biosero is well-positioned to capitalize on the transition toward fully autonomous, data-driven laboratory ecosystems. Future growth will likely involve scaling their software-as-a-service offerings to provide more robust analytics and predictive maintenance for automated lab fleets.
See full Biosero company page
